Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Opthea Opens Patient Enrollment in the Asia-Pacific Region

20 Oct 2021  |  08:26:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Opthea opens patient enrollment in the Asia-Pacifi Region

Opthea announced that the first clinical trial sites in the Asia-Pacific region are open for patient enrollment into the OPT-302 Phase 3 pivotal clinical program for the treatment of wet (neovascular) age-related macular degeneration (AMD). The clinical trial sites, located in Australia, further build upon the progress of other international regions including the U.S., Canada and Europe that are also actively recruiting patients.

Please click here for full details

See more ASX300 News Announcements